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Abstract
Phosphorylcholine (PC) is increasingly becoming recognised as a carbohydrate-associated component of a wide variety of
procaryotic and eucaryotic pathogens. Studies employing nematode PC-containing molecules indicate that it possesses a
plethora of immunomodulatory activities. ES-62 is a PC-containing glycoprotein, which is secreted by the rodent filarial
nematode Acanthocheilonema viteae and which provides a model system for the dissection of the mechanisms of immune
evasion induced by related PC-containing glycoproteins expressed by human filarial nematodes. At concentrations
equivalent to those found for PC-containing molecules in the bloodstream of parasitised humans, ES-62 is able to inhibit
antigen receptor-stimulated proliferation of B and T lymphocytes in vitro and in vivo. The active component of ES-62
appears to be PC, as PC conjugated to albumin or even PC alone broadly mimic the results obtained with ES-62. PC-induced
impaired lymphocyte responsiveness appears to reflect uncoupling of the antigen receptors from key intracellular
proliferative signalling events such as the phosphoinositide 3-kinase, protein kinase C and Ras mitogen-activating protein
kinase pathways. Although PC-ES-62 can desensitise B and T cells, not all cells are affected, and in fact it is still possible to
generate an antibody response to the molecule. Dissection of this response indicates that it is of the TH-2 type. This appears
to reflect the ability of ES-62 to direct the polarity of the T cell response by suppressing the production of proinflammatory
cytokines, inducing the induction of anti-inflammatory cytokines and by driving the maturation of dendritic cells that direct
TH-2 T cell responses. ß 2001 Elsevier Science B.V. All rights reserved.
Keywords: Cytokine; Immunomodulation; Lymphocyte; Nematode; Phosphorylcholine; Signal transduction
1. Introduction
1.1. Filarial nematode parasites and evasion/
modulation of the host immune system
Filarial nematodes are arthropod-transmitted par-
asites of vertebrates including humans. Of the eight
species, which are known to infect humans, three,
Wuchereria bancrofti, Brugia malayi and Onchocerca
volvulus, represent major causes of morbidity in the
Tropics [1]. It is currently estimated that in the re-
gion of 150 million people are infected with one or
more of these three worms and a signi¢cant propor-
tion of these individuals su¡er debilitating health
problems. These include elephantiasis, severe and
chronic skin lesions and several forms of eye damage,
all of which can lead to blindness.
Infection of humans (or animals) with ¢larial nem-
0167-4889 / 01 / $ ^ see front matter ß 2001 Elsevier Science B.V. All rights reserved.
PII: S 0 1 6 7 - 4 8 8 9 ( 0 1 ) 0 0 1 0 1 - X
* Corresponding author. Fax: +44-141-548-3427;
E-mail : w.harnett@strath.ac.uk
BBAMCR 14756 21-5-01
Biochimica et Biophysica Acta 1539 (2001) 7^15
www.bba-direct.com
atodes is long term with individual worms surviving
for in excess of 5 years [2]. The consensus of opinion
amongst workers in this ¢eld is that such longevity
re£ects suppression or modulation of the host im-
mune system and indeed ‘defects’ in immune respon-
siveness have been revealed in infected individuals
[3,4]. The exact nature of these defects is uncertain:
there appears to be a lack of uniformity in ¢ndings
from the many studies undertaken to de¢ne them.
Nevertheless, in general the defects incorporate im-
pairment of lymphocyte proliferation and bias in
production of both cytokines and antibodies. With
respect to cytokines the bias can be shown in reduced
IFN-Q and increased IL-10. For antibodies, there are
imbalances in IgG subclasses: greatly elevated IgG4
(an antibody of little value in eliminating pathogens
due to an inability to activate complement or bind
with high a⁄nity to phagocytic cells), and decreases
in other IgG subclasses. Overall therefore, the picture
is of an immune response demonstrating a somewhat
suppressed, anti-in£ammatory phenotype which is
often classi¢ed as ‘TH-2’ (‘TH’ is derived from a
category of T lymphocyte referred to as ‘helper’). It
has been speculated that such a phenotype is condu-
cive to both parasite survival and host health (the
latter by limiting pathology resulting from an aggres-
sive immune response). At present, the mechanism
underlying its induction is probably the most fre-
quently addressed question in research into the im-
munology of ¢lariasis.
1.2. Phosphorylcholine: an immunomodulator during
¢larial nematode infection?
Phosphorylcholine (PC) is an abundant compo-
nent of eucaryotes, both vertebrates and inverte-
brates, where it is found as the polar head group
of the phospholipids, phosphatidylcholine and sphin-
gomyelin. However, in certain bacteria, fungi and
lower invertebrates including ¢larial nematodes, PC
has been found in a di¡erent association, speci¢cally,
attached to carbohydrate (reviewed in [5]). In ¢larial
nematodes, PC has been found attached to both gly-
colipids [6] and glycoproteins (reviewed in [7]). Some
of the latter are secreted by the worms and can in-
deed be detected in the bloodstream of infected in-
dividuals [8]. A major puzzle in ¢larial nematode
research is the role of PC on these secreted proteins.
PC is a chemical group known to a generation of
immunologists due to its potent immunogenicity
making it a suitable antigen for use in experiments
investigating the generation and diversity of the anti-
body response [9,10]. This potent immunogenicity
also dictates that it can act as a dominant hapten
during nematode infections. Thus many human ¢lar-
iasis patients have signi¢cant anti-PC responses [11^
13], strong anti-PC responses appear rapidly during
experimental infections of animals [14^16] and in-
deed the latter may dominate the antibody response
to the parasite. Likewise, PC appears to be a, if not
the, major antigenic determinant of certain species of
bacteria, e.g., Streptococcus pneumoniae [17,18].
However, occasionally during the last 25 years, a
paper has appeared in the literature, which questions
the idea that PC’s e¡ect on the immune system is
simply to activate it. In 1976, for example, Mitchell
and Lewers [14] showed that conjugation of PC to
some molecules reduced their immunogenicity. In
1991, Sloan and colleagues [19] demonstrated that
successful immunotolerance against PC was associ-
ated with increases in antibodies to other epitopes
in Fasciola hepatica-infected mice. In 1998 Bordmann
and coworkers [20] indicated that exposure of mice
to PC resulted in TH-2 cytokine production. Such
e¡ects on the immune system are to some degree
consistent with what is observed during ¢larial nem-
atode infection. For this reason we explored the idea
that the function of PC on secreted nematode pro-
teins is to modulate the host immune response.
2. E¡ect of phosphorylcholine on lymphocyte signal
transduction pathways
2.1. Inhibition of lymphocyte proliferation by PC on
ES-62
It has been known for almost two decades that a
percentage of B lymphocytes (murine and human)
expresses a non-immunoglobulin receptor for PC
[21]. Interaction of this receptor with PC-containing
S. pneumoniae results in the polyclonal secretion of
antibody from the cells [22]. It may therefore be pre-
dicted that interaction of PC-containing molecules of
¢larial nematodes with B lymphocytes would also
result in polyclonal antibody production. This in
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fact may well be the case as incubation of ES-62, a
well-characterised PC-containing molecule secreted
by the rodent ¢larial nematode Acanthocheilonema
viteae [23], with small resting spleen-derived murine
B lymphocytes results in cell activation as measured
by DNA synthesis [23]. However, this e¡ect of ES-62
was noted when ‘high’ concentrations were employed
(25^50 Wg ml31). Interestingly, at concentrations 10^
100-fold less, i.e., within the range at which PC-con-
taining molecules can be found in the human blood-
stream [24], ES-62 does not cause polyclonal stimu-
lation. Rather, it acts to prevent (by up to 60%)
proliferation of B lymphocytes associated with liga-
tion of the antigen receptor [23]. This e¡ect of ES-62
is almost certainly due to PC as PC conjugated to
bovine serum albumin (BSA) or even PC alone can
mimic it. Furthermore, weekly injections of PC^BSA
(10 Wg) into mice was found to reduce the ability of
recovered B lymphocytes to be activated via the anti-
gen receptor [25]. These latter inhibitory e¡ects of
ES-62/PC on subsequent activation of B lymphocytes
suggests that exposure to low levels of PC may ac-
tually anergise B cells. This will be discussed in some
detail later.
It was also found that ES-62 was able to inhibit
polyclonal activation via the antigen receptor of the
human T cell line Jurkat [26] and again this e¡ect
appears to be mainly due to PC [25]. These results
are consistent with an earlier ¢nding that PC-con-
taining molecules isolated from a whole worm ex-
tract of the human ¢larial nematode Brugia malayi
could inhibit activation of human T lymphocytes in-
duced by the mitogen phytohaemagglutinin [27]. In-
hibition of T lymphocyte proliferation during ¢larial
nematode infection has been a much more frequently
documented phenomenon than the same e¡ect on its
B lymphocyte counterpart. However, we are only
currently beginning to investigate whether PC con-
tributes to this in vivo.
2.2. Mechanism of action of ES-62/PC
We have undertaken considerable e¡ort in at-
tempting to elucidate how PC inhibits lymphocyte
activation associated with ligation of the antigen re-
ceptor. Revealingly, although the concentrations of
ES-62 which interfere with activation of B lympho-
cytes induce no activation of the cells per se as mea-
sured by DNA synthesis, they a¡ect a number of
signalling elements associated with the transduction
of cellular activation and proliferation. Thus, pre-
treatment with the parasite molecule has been found
to: (1) induce tyrosine phosphorylation and activa-
tion of the protein tyrosine kinases (PTKs) Lyn, Syk
and Blk but not Fyn [28]; (2) phosphorylate and
activate the Erk2 isoform of mitogen-activated pro-
tein (MAP) kinase [28]; (3) downregulate the total
level and activity of protein kinase C (PKC) [23];
and (4) modulate the expression of a number of
PKC isoforms (for example, whereas K, L, S/V, N
and j are downregulated, expression of Q and O is
upregulated) [29]. That ES-62-induced modulation
of these signal transducers requires PC is demon-
strated by the fact that the e¡ects on the PTKs,
Erk2 and overall PKC levels at least, are known to
be mimicked by PC [23,28]. Importantly, we have
also found that pre-exposure of B cells to ES-62 at
the low concentrations serves to almost completely
desensitise the cells to subsequent activation via the
B cell receptor (BCR) of the phosphoinositide 3-ki-
nase (PI-3-kinase) and Ras-MAPK pathways [28].
Thus, uncoupling of the BCR from these crucial pro-
liferative pathways could provide a molecular mech-
anism for the ES-62-mediated inhibition of BCR-
driven proliferation of B lymphocytes. More recently
[26], we have found that the ES-62-induced rendering
of Jurkat cells anergic to cellular activation via the
T-cell antigen receptor (TCR) is associated with dis-
ruption of TCR coupling to the phospholipase D,
PKC, PI-3-kinase and Ras-MAPK signalling cas-
cades. As with murine B cells, however [23], the
PLC-mediated generation of inositol phosphates is
not a¡ected. Again, as for inhibition of BCR signal-
ling, PC appears to be the active component of the
parasite molecule. Thus, culture with PC or PC^BSA
has similar e¡ects to ES-62 on the coupling of the
TCR to tyrosine kinase activation (ZAP-70, Lck and
Fyn) and the PLC, Ras and MAP kinase signalling
cascades [25].
In B lymphocytes, coupling of the antigen recep-
tors to Erk MAP kinase is PTK-dependent [30]. Fol-
lowing ligation of the BCR, Lyn, tyrosine phosphor-
ylates the immunoreceptor tyrosine-based activation
motifs (ITAMs) on the accessory transducing mole-
cules Ig-K and Ig-L. This leads to the recruitment and
activation of additional PTKs (such as Syk, Blk and
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Fyn) and also signalling molecules (PLC-Q, RasGAP)
and adaptors (Shc, Grb2) in a SH2 and SH3 domain-
dependent manner. Thus, Shc binds to the phosphor-
ylated ITAMs and in turn is phosphorylated by Syk
permitting recruitment of the Grb2Sos complexes re-
quired for activation of Ras at the plasma mem-
brane. Following Sos-driven guanine nucleotide ex-
change and generation of the GTP-bound form of
Ras, Ras binds and derepresses Raf-ser/thr kinase,
triggering stimulation of MEK (MAP kinase kinase)
and consequent activation of MAP kinase. Although
we have found that ES-62 profoundly suppresses
BCR-stimulated tyrosine events, it does not appear
to uncouple the BCR from MAP kinase activation
by disrupting activation of the BCR-associated pro-
tein tyrosine kinases such as Lyn, Syk, Blk or Fyn
[28]. Conversely, we have found that ES-62/PC ap-
pears to target two major negative regulatory sites in
the control of BCR coupling to the Ras MAP kinase
cascade. Speci¢cally, it induces the activation of
SHP-1 tyrosine phosphatase and the MAP kinase
phosphatase, Pac-1 (M.R. Deehan, W. Harnett and
M.M. Harnett, unpublished data). Activation of the
former results in dephosphorylation of ITAMs on
Ig-L and hence loss of recruitment of other signalling
molecules; activation of the latter results in dephos-
phorylation and hence inactivation of MAP kinase.
Fig. 1 summarises known e¡ects of ES-62/PC on
signal transduction via the BCR.
How then is PC able to exert these e¡ects on lym-
phocyte signal transduction pathways? Examination
of the literature reveals clear evidence from a number
of studies for PC playing a role in cellular prolifer-
ation. For example, many human tumours have ele-
vated levels of PC [31] and Ras-transformed cell lines
produce increased levels, which are necessary for cell
proliferation [32]. Furthermore, it has recently been
found that PC can exert mitogenic and co-mitogenic
e¡ects on ¢broblast cell lines in vitro [33] and this is
associated with activation of MAP kinase [34]. Thus,
since it has been shown for B lymphocytes that ES-
62 does not itself induce the generation of cellular PC
[28], it is conceivable that the PC component of ES-
62 could result in partial activation of B cells which
renders them desensitised to subsequent activation
via the BCR. However, evidence has been produced
indicating that the mitogenic e¡ects of PC can occur
not only intracellularly but also following extracellu-
lar interaction with PC [35]. With respect to ES-62,
we cannot at this stage state whether the PC moiety
acts at the cell surface or following internalisation.
The ability of PC to activate certain protein tyrosine
kinases, which are associated with receptors found at
the plasma membrane [28], may be an argument in
favour of the former. It is also worth considering,
however, that it may be possible for ES-62 to become
Fig. 1. ES-62 uncoupling of the BCR-RasErkMAP kinase cas-
cade. Following ligation of the BCR the kinase, Lyn, tyrosine
phosphorylates the ITAMs on the accessory transducing mole-
cules Ig-K and Ig-L. The Ras adaptor protein, Shc, binds to the
phosphorylated ITAMs and in turn is phosphorylated leading
to the recruitment of the Grb2Sos complexes (Grb2 is an adap-
tor protein which binds Sos, a guanine nucleotide exchange fac-
tor) required for activation of the GTPase, Ras. Active Ras ini-
tiates the Erk MAP kinase cascade by binding and activating
the ser/thr kinase, Raf, leading to stimulation of the thr/tyr ki-
nase MEK and consequent activation and nuclear translocation
of the ser/thr kinase Erk. ES-62/PC signalling appears to target
two major negative regulatory sites in the control of BCR cou-
pling to the Ras MAP kinase cascade. Firstly, ES-62 signalling
promotes the BCR activation of SHP-1 tyrosine phosphatase to
prevent initiation of BCR signalling by maintaining the ITAMs
in a resting, dephosphorylated state and hence prevents recruit-
ment of the ShcGrb2Sos complexes required to activate Ras.
Secondly, ES-62 signalling promotes the BCR-driven association
of the nuclear MAP kinase dual (thr/tyr) phosphatase, Pac-1,
with Erk to terminate any ongoing Erk signals. This dual-
pronged mechanism results in a rapid and profound desensitisa-
tion of BCR coupling to the RasErkMAP kinase cascade.
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readily internalised by lymphocytes, perhaps follow-
ing interaction with a speci¢c receptor. Certainly, the
PAF receptor is utilised by PC-containing S. pneumo-
niae to enter human endothelial cells during infection
[36] and it is known that B lymphocytes express PAF
receptors at the plasma membrane [37] (whether the
PAF receptor is the uncharacterised receptor referred
to earlier [21], awaits elucidation). Regardless of
where ES-62 acts, what is interesting about the acti-
vation of MAP kinase induced by the parasite prod-
uct is that it appears to take place in the absence of
Ras activation [28]. Recent studies in our laborato-
ries indicate that ES-62/PC actually blocks Ras acti-
vation by preventing association between Shc and
the Ras guanine nucleotide exchange factor Sos
(M.R. Deehan, W. Harnett and M.M. Harnett, un-
published data). The alternative mechanism by which
MAP kinase is activated remains to be established
but whatever it is, as mentioned earlier, it clearly fails
to result in cell proliferation.
3. E¡ect of phosphorylcholine on antibody and
cytokine responses
The observation that the e¡ect of PC on B lym-
phocytes in vitro varies with respect to concentration
suggests that its e¡ects in vivo may be phenotypically
diverse. Thus, it is possible to predict that infected
individuals exposed to low levels of PC might have
suppressed antibody responses to parasite molecules
whereas those exposed to high levels might be subject
to increased polyclonal production of immunoglob-
ulin. Review of the literature as it currently stands
suggests we have some way to go before we have
fully characterised the e¡ects of ¢larial nematode in-
fection on host antibody production but certainly
there is evidence for both types of individual existing
[38^40]. The situation is complicated, however, by
the ¢nding referred to earlier that people harbouring
¢larial nematodes often show a bias in antibody
class/subclass production. In particular, it is fre-
quently noted that IgG4 and IgE levels (both speci¢c
and non-speci¢c) are greatly elevated whereas levels
of IgG1, IgG2 and IgG3 may be reduced (reviewed
in [41,42]). Intriguingly, we have recently discovered
that the combination of IL-4 and ES-62, the latter in
concentrations that render B cells anergic to activa-
tion via the antigen receptor, actually synergises to
produce B lymphocyte activation in vitro [25]. This
may relate to our earlier ¢nding that IL-4 can over-
come the downregulatory e¡ects of ES-62 on PKC-K
and S/V expression in B cells [29] as these PKC iso-
forms are considered to transduce key activation sig-
nals [43,44]. Since IgG4 and IgE are promoted by IL-
4, a similar synergistic activation occurring in vivo
might o¡er an explanation for the increased produc-
tion of these types of antibody. Having said all of
this, however, it is important to note that we cur-
rently have no real proof that PC is modulating anti-
body responses during ¢larial nematode infection.
Nevertheless, we have recently obtained some evi-
dence con¢rming that the presence of PC on ES-62
modulates the antibody response to other epitopes
on the molecule [45]. However, as shown below,
the mechanism responsible for this e¡ect does not
seem to be dependent on IL-4.
In spite of its apparent ability to desensitise lym-
phocytes, jirds naturally infected with A. viteae
mount an IgG antibody response to ES-62 [46].
BALB/c mice subjected to subcutaneous exposure
to ES-62 also mount an antibody response [25].
When this is examined with respect to the TH-1
and TH-2 signature IgG subclasses ^ IgG2a and
IgG1 respectively ^ it is found that only the latter
is produced [25]. Thus, ES-62 induces a TH-2 anti-
body response. That this is dependent on IL-4 was
shown by its absence in the IL-4 knockout (KO)
mouse [45]. ES-62 induces the production of a little
IL-12 by murine spleen cells (W. Harnett, unpub-
lished data). This cytokine is essential for induction
of the TH-1 phenotype but induction does not occur
in the presence of IL-4 as the latter cytokine inhibits
TH-1 cell development by downregulating the L-
chain of the IL-12 receptor [47]. It might therefore
be predicted that the IL-4 KO mouse would make a
compensatory IgG2a response as has been observed
in the response to adult B. malayi [48]. No IgG2a
response to ES-62 is detected, however [45], indicat-
ing that such a response is not being ‘blocked’ by IL-
4. Thus either ES-62 simply does not induce a TH-1
response or it is being inhibited in some other way.
ES-62 lacking PC can be produced by culturing A.
viteae in the presence of 1-deoxymannojirimycin
(dMM) [49] or hemicholinium-3 (HC-3) [50]. The
former is a mannose analogue which inhibits an ol-
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igosaccharide processing step on glycoproteins [51]
which is necessary for the generation of the substrate
for PC addition to ES-62 [49,52]. The latter is a cho-
line kinase inhibitor and hence prevents synthesis of
PC [53]. When PC-free ES-62 prepared in either way
was injected into BALB/c mice, subsequent ELISA
analysis of recovered serum samples found that there
was no signi¢cant e¡ect on the previously noted [25]
IgG1 antibody response to non-PC epitopes of the
parasite product [45] (Fig. 2). Unlike the results ob-
tained with normal ES-62, however, the PC-free ma-
terial was able to induce a substantial IgG2a re-
sponse [45] (Fig. 2). This implicates a role for PC
in blocking the IgG2a response. We thus investigated
whether the addition of PC to BSA would inhibit
any IgG2a antibody response associated with it.
Although it was found that the BALB/c IgG2a re-
sponse to BSA was relatively weak, the presence of
PC did indeed appear to be inhibiting it [45].
It has previously been reported that the PC moiety
of ¢larial nematodes can induce IL-10 production in
B1 cells [54]. IL-10 can downregulate production of
IFN-Q production, the cytokine necessary for anti-
body class switching to IgG2a in mice [55,56].
Thus, to determine whether PC was blocking produc-
tion of IgG2a antibodies by promoting production of
IL-10, the antibody response to normal ES-62 in IL-
10 KO mice was investigated. When ES-62 was in-
jected into these mice, an IgG2a response to the par-
asite molecule was generated [45]. This result there-
fore implicates PC-induced IL-10 as playing a role in
determining the nature of the IgG subclass response
to ES-62.
As might be expected from the results of the IL-10
KO mouse study, ES-62 is able to induce production
of IL-10 in naive BALB/c spleen cells [25]. Although
we have not investigated whether this is due to the
PC component of the molecule, this would be pre-
dicted from the work of Hoerauf and colleagues,
who showed that PC causes release of this cytokine
from B1 cells [54,57]. However, we have also found,
as mentioned earlier, that ES-62 promotes the release
from naive spleen cells of IL-12 and, in addition,
IFN-Q [25], two cytokines associated with the TH-1
axis of the immune response. Again, we have not
investigated whether this is due to PC. We are de-
scribing these results, however, in the context of data
obtained by Lochnit and colleagues [58] which dem-
onstrated that PC on glycolipids of Ascaris suum in-
duces human peripheral blood mononuclear cells to
release the proin£ammatory cytokines TNFK, IL-1
and IL-6. Thus although the immunomodulatory
relevance of these observations is uncertain (the gly-
colipids are internal worm components and hence
may not have an opportunity to interact with the
host immune system), PC clearly has the potential
to be more than simply an inducer of cytokines in-
volved in promoting TH-2 responses. Having said
this, however, we have recently found that although
ES-62 can induce a low level production of IL-12 in
macrophages, it also blocks the subsequent substan-
tial production of this cytokine (and also IL-6 and
TNFK, but not nitric oxide) induced by LPS/IFN-Q
(H. Goodridge et al., unpublished data).
It has already been alluded to that the phenotype
of an acquired immune response is considered to
re£ect the early cytokine environment in which naive
CD4 T cells interact with antigen. Again, it has
been suggested, for example, that early exposure to
IL-4 can push an immune response in a TH-2 direc-
tion [59]. We therefore investigated (by ELISA)
whether ES-62 was able to spontaneously induce
IL-4 secretion in naive murine spleen cells (48 h ex-
posure). Ironically, given that the molecule induces a
TH-2 antibody response and seems to be able to
Fig. 2. Comparison of IgG1 and IgG2a antibody levels against
ES-62 in BALB/c mice exposed to either native ES-62 or ES-62
synthesised in the presence of dMM. Groups of three 6^8-
week-old female BALB/c mice were given a total of four subcu-
taneous injections of puri¢ed parasite material (3 Wg per injec-
tion) each 1 week apart. Serum samples were collected on a
weekly basis and assayed by ELISA. Identical results were ob-
tained when HC-3 was employed to produce PC-free ES-62.
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induce the release of a number of other cytokines,
IL-4 was not detected [25]. It was noted, however,
that spleen cells from mice that had been pre-exposed
to ES-62 produced IL-4. This ‘established’ TH-2 phe-
notype is consistent with the antibody data.
More recently, we have investigated the ability of
ES-62 to prime immune responses via dendritic cells
[60]. These are specialised antigen presenting cells
required for the priming and activation of CD4 T
cells and as such, could potentially direct the subse-
quent di¡erentiation of T cell function [61]. We em-
ployed a well characterised in vitro TH cell assay in
which CD4 T cells from the DO.11.10 transgenic
mouse express a T cell receptor that is speci¢c for
an ovalbumin peptide [62]. When these naive CD4
T cells are cultured with bone marrow-derived den-
dritic cells in the presence of the peptide they secrete
both IFN-Q and IL-4. However, we found that if the
dendritic cells were precultured in the presence of
ES-62, then there was an increase in the amount of
IL-4 produced and a decrease in the amount of IFN-
Q [60]. Thus ES-62 is found to induce the maturation
of dendritic cells with the capacity to induce TH-2
responses. The next step will be to investigate
whether this is due to PC. We also need to investi-
gate the molecular mechanism underlying this e¡ect
^ our initial observations suggest that it is not due to
IL-10 or upregulation of known costimulatory mol-
ecules on the dendritic cell surface.
4. Concluding remarks and future prospects
PC has been suggested as meeting the requirements
for a general vaccine targetted against mucosal
pathogens [63] and indeed anti-PC antibodies can
protect against various bacterial infections (S. pneu-
moniae, Salmonella typhimurium) (reviewed in [5,63]).
Furthermore, ¢larial nematode infective larvae, a
stage possibly unique in expressing PC on their sur-
face, may also be susceptible to host antibody-medi-
ated immunity [57]. However, it is becoming in-
creasingly apparent that PC has a number of
immunomodulatory properties, which dictates that
caution should be exercised when considering its
use in vaccination. By secreting PC-containing mol-
ecules, adult ¢larial nematodes appear to have uti-
lised these immunomodulatory properties to manip-
ulate the host immune system in certain ways and
hence aid their survival in the parasitised host.
What could be of interest therefore would be to ex-
plore the use of PC not for vaccination, but for ma-
nipulating immune responses in ways analogous to
those being demonstrated by the parasites. One won-
ders for example whether molecules such as PC, by
pushing immune responses in an anti-in£ammatory,
TH-2 direction, might be of value in the treatment of
autoimmune diseases such as rheumatoid arthritis.
Clearly, however, the fact that PC appears to have
a plethora of immunomodulatory activities, some of
which in fact appear to be proin£ammatory, dictates
that much more investigation has to be carried out
on this intriguing molecule, prior to considering its
use in therapies.
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